Research Disclosures & Disclaimers
This website contains disclosures and disclaimers related topublished UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.
Valiant Holding AG - Sponsored Research (VATN.S)
UBS Rating and Price Target History Chart
EQ Rating & Price Target Table | ||||||||||||||||||||||||||||||||||||
|
Disclosures
- UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
- Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
- UBS has entered into a contract with SIX whereby UBS may (at its discretion) provide research coverage about issuers nominated by SIX. Under the terms of that contract UBS will receive a flat fee of CHF 30,000 per annum from SIX for a period of two years from the time of initiation for the creation and dissemination of research about the relevant issuer. This issuer is covered by UBS pursuant to that contract.
- UBS holds a long or short position of 0.5% or more of the listed shares of this company.
- UBS Fund Management (Switzerland) AG beneficially owns more than 10% of the total issued share capital of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.